Skip to content
Search

Latest Stories

MHRA partners with US firm to train staff using VR-based educational platform

The Medicines and Healthcare products Regulatory Agency (MHRA) has partnered with US-based Quality Executive Partners (QxP) to train staff on good manufacturing practices (GMP) standards using a virtual reality-based on-demand educational platform.

A team of experts from the drug regulator’s GMP Inspectorate participated as QxP’s beta partners in the pilot of its 'Virtuosi' platform, the life sciences management consulting firm has revealed.


They reviewed selected educational lecture content and VR experiences that stimulate daily operations within controlled manufacturing and microbiology laboratory settings.

"MHRA promotes innovation across all stages of the pharmaceutical lifecycle and provides regulatory advice to stakeholders through initiatives such as its Innovation Office. The MHRA’s inspectorate welcomes the opportunity to support and adopt new technology such as innovative approaches to delivering education," an MHRA spokesperson told Pharmacy Business.

The VR-based platform, first of its kind in the world, was officially launched on Tuesday.

“We are so pleased to have the benefit of MHRA’s review and perspectives within our Virtuosi Sterile Manufacturing and Microbiology series," said Crystal Mersh, CEO of QxP.

Mersh stated that the MHRA already received the first deployed VR workstation and that it would be upgraded to a full commercial release later this month.

“The MHRA team has been a key regulatory supporter during our journey in developing this commercial VR educational technology," Mersh added.

QxP expects the workstation to act as an innovative source of internal training for the MHRA GMP Inspectorate.

More For You

GP surgery upgrades for annual appointments

The surgeries will have additional space to “see more patients, boost productivity and improve patient care”

Pic credit: iStock

GP surgery upgrades to create 8.3 million more annual appointments

Over 1,000 GP surgeries will have their premises modernised to meet the needs of a further 8.3 million appointments each year, the government has announced.

Backed by a cash injection of over £102 million, the surgeries will have additional space to “see more patients, boost productivity and improve patient care”.

Keep ReadingShow less
Wales boosts funding for pharmacy-led UTI and sore throat test services

The sore throat test (STTT) and treat service will be widely available

Pic credit: istock

Welsh pharmacies receive funding boost for clinical services

Two key clinical services will be available in 99 per cent of community pharmacies across Wales after a boost in funding.

The sore throat test (STTT) and treat service and the urinary tract infection (UTI) service have both benefitted from contractual negotiations between the Welsh Government and Community Pharmacy Wales (CPW).

Keep ReadingShow less
Paul Bennett
Paul Bennett, CEO, Royal Pharmaceutical Society
Paul Bennett, CEO, Royal Pharmaceutical Society

Pharmacists need to take advantage of independent prescribing pathways, says Bennett

Independent prescribing will be a “significant point” in the history of community pharmacy, according to Royal Pharmaceutical Society chief executive Paul Bennett.

Last month, the RPS announced the launch of a comprehensive new prescribing development programme to support pharmacists across all stages of their prescribing careers.

Keep ReadingShow less
Community Pharmacy Scotland secures £10m reimbursement uplift amid ongoing negotiations

Negotiations continue on the Global Sum element of remuneration.

Getty Images

Community Pharmacy Scotland secures £120m reimbursement deal for 2025/26

Community Pharmacy Scotland (CPS) has accepted the Scottish government’s initial financial offer for the 2025/26 fiscal year, securing a guaranteed minimum reimbursement of £120 million for community pharmacies — up from £110 million from 2024/25.

The agreement marks the first phase of ongoing negotiations surrounding community pharmacy funding for the upcoming financial year.

Keep ReadingShow less